Squarepoint’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$358K Buy
+26,500
New +$371K ﹤0.01% 3572
2025
Q4
Sell
-18,600
Closed -$184K 4956
2025
Q3
$184K Buy
+18,600
New +$181K ﹤0.01% 3972
2025
Q1
Sell
-20,000
Closed -$249K 5495
2024
Q4
$249K Buy
+20,000
New +$246K ﹤0.01% 4303
2021
Q3
Sell
-300,200
Closed -$4.29M 3474
2021
Q2
$4.29M Buy
300,200
+200
+0.1% +$2.89K 0.02% 793
2021
Q1
$4.19M Buy
+300,000
New +$4.89M 0.02% 707

Other funds holding VTRS

Squarepoint's VTRS Position: Q1 2026 in Review

Squarepoint increased its Viatris (VTRS) stake by 15% in Q1 2026, buying an estimated $4.12M and bringing the position to 2,273,599 shares worth $30.7M. The position accounts for 0.04% of the portfolio, ranked #501.

Squarepoint first reported a position in VTRS in Q3 2015 and has held it in 37 quarters since. 1,019 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.

  • Squarepoint held 2,273,599 shares of Viatris worth $30.7M as of Q1 2026.
  • Squarepoint bought 294,228 Viatris shares in Q1 2026, an estimated $4.12M.
  • Viatris made up 0.04% of Squarepoint's portfolio in Q1 2026, its #501 holding.
  • Squarepoint first reported a position in Viatris in Q3 2015 and has held it in 37 quarters since.
  • 1,019 funds tracked by Wall St. Rank held Viatris as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.